Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The c-kit protein tyrosine kinase, also known as CD117 or stem cell factor receptor (SCFR), is a type III receptor tyrosine kinase encoded by the KIT proto-oncogene. It plays essential roles in normal physiology and disease, particularly in hematopoiesis, pigmentation, gametogenesis, and cancer. Dysregulation of c-KIT occurs via overexpression or activating mutations. Inhibitors targeting the ATP-binding site of mutant/overactive Kit have shown clinical efficacy.
ATP-binding site inhibition of mutant/overactive Kit
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on c-kit protein tyrosine kinase (c-KIT).